Getinge AB (publ) GETI-B.ST
SE · Nasdaq Stockholm · XSTO · stock · Healthcare · website
Getinge AB (publ) financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | kr 35.0B | kr 34.8B | kr 31.8B | kr 28.3B |
| Gross profit | kr 16.7B | kr 16.2B | kr 14.5B | kr 13.4B |
| R&D expense | kr 1.5B | kr 1.4B | kr 1.2B | kr 1.2B |
| SG&A expense | kr 9.5B | kr 9.6B | kr 8.7B | kr 8.4B |
| Operating income | kr 4.5B | kr 3.7B | kr 3.7B | kr 3.9B |
| Interest expense | kr 660.0M | kr 606.0M | kr 469.0M | kr 205.0M |
| Income tax | kr 869.0M | kr 628.0M | kr 915.0M | kr 956.0M |
| Net income | kr 2.3B | kr 1.6B | kr 2.4B | kr 2.5B |
| EPS (diluted) | kr 8.29 | kr 6.01 | kr 8.86 | kr 9.15 |
| Operating cash flow | kr 3.9B | kr 4.6B | kr 3.0B | kr 3.4B |
| Free cash flow | kr 2.6B | kr 3.3B | kr 1.6B | kr 2.2B |
| Cash & equivalents | kr 3.4B | kr 3.0B | kr 2.7B | kr 5.7B |
| Inventory | kr 6.0B | kr 6.6B | kr 6.4B | kr 6.2B |
| Goodwill | kr 25.8B | kr 30.1B | kr 24.9B | kr 22.5B |
| Total assets | kr 56.5B | kr 63.9B | kr 53.6B | kr 52.0B |
| Total debt | kr 10.9B | kr 10.7B | kr 8.1B | kr 5.8B |
| Total liabilities | kr 27.0B | kr 30.7B | kr 23.2B | kr 21.6B |
| Shareholders' equity | kr 29.4B | kr 33.0B | kr 30.2B | kr 30.0B |
Growth · year-over-year · Revenue CAGR 7.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +0.6% | +9.2% | +12.5% | — |
| Net income growth | +37.9% | -32.1% | -3.2% | — |
| EPS growth | +37.9% | -32.2% | -3.2% | — |
| Free cash flow growth | -19.4% | +103.7% | -28.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · SE · as of 2025-12-31. Figures in SEK. Facts plus Stocktoria's own computed scores — not investment advice.